Risk factors of arterial cardiovascular complications in patients with prior venous thromboembolism

Netherlands Journal of Medicine

Volumn 69, Issue 1, 2011, Pages 27-30

  Roshani, S ^a,b   Lijfering, W M ^b,c   Coppens, M ^a   Hamulyak K ^d   Prins, M H ^d   Buller H R ^a   Middeldorp, S ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular diseases; Risk factors; Thrombophilia; Venous thromboembolism

Indexed keywords

ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; SCORING SYSTEM; THROMBOPHILIA; TRANSIENT ISCHEMIC ATTACK; VENOUS THROMBOEMBOLISM;

AGE FACTORS; ARTERIES; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 79952079333     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, et al. An Association between atherosclerosis and venous thrombosis. N Engl J Med. 2003;348:1435-41.
2. Becattini C, Agnelli G, Prandoni P, Silingardi M, Salvi R, Taliani MR, et al. A Prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J. 2005;26:77-83.
3. Prandoni P, Ghirarduzzi A, Prins MH, Pengo V, Davidson BL, Sorensen H, et al. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J Thromb Haemost. 2006;4:1891-6.
4. Young L, Ockelford P, Milne D, Rolfe-Vyson V, Mckelvie S, Harper P. Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality. J Thromb Haemost. 2006;4:1919-24.
5. Schulman S, Lindmarker P, Holmstrom M, Larfars G, Carlsson A, Nicol P, et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost. 2006;4:734-742.
6. Klok FA, Mos IC, Broek L, Tamsma JT, Rosendaal FR, de Roos A, et al. Risk of arterial cardiovascular events in patients after pulmonary embolism. Blood. 2009;114:1484-8.
7. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008;117:93-102.
8. Biere-Rafi S, Zwiers M, Peters M, van der Meer J, Rosendaal FR, Buller HR. The effect of haemophilia and Von Willebrand disease on arterial thrombosis: a systematic review. Neth J Med. 2010;68:207-14.
9. Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM, Jr., Kastelein JJ, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med. 2009;360:1851-61.
10. Reich LM, Folsom AR, Key NS, Boland LL, Heckbert SR, Rosamond WD, et al. Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. J Thromb Haemost. 2006;4:1909-13.
11. van der Hagen PB, Folsom AR, Jenny NS, Heckbert SR, O'Meara ES, Reich LM, et al. Subclinical atherosclerosis and the risk of future venous thrombosis in the cardiovascular health study. J Thromb Haemost. 2006;4:1903-8.
12. Lijfering WM, Coppens M, van de Poel MH, Middeldorp S, Hamulyak K, Bank I, et al. The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects. Thromb Haemost. 2007;98:457-63.
13. Coppens M, van de Poel MH, Bank I, Hamulyak K, van der Meer J, Veeger NJ, et al. A Prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation. Blood. 2006;108:2604-7.
14. Bank I, van de Poel MH, Coppens M, Hamulyak K, Prins MH, van der Meer J, et al. Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study. Thromb Haemost. 2007;98:1040-4.
15. Sturmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S. A Review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol. 2006;59:437-47.
16. Bova C, Marchiori A, Noto A, Rossi V, Daniele F, Santoro C, et al. Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study. Thromb Haemost. 2006;96:132-6.
17. Sorensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet. 2007;370:1773-9.